Literature DB >> 29524585

Mining the tree of life: Host defense peptides as antiviral therapeutics.

Jessica R Shartouny1, Joshy Jacob2.   

Abstract

Discovering new therapeutics for human viral diseases is important for combatting emerging infectious viruses and omnipresent circulating viruses as well as those that can become resistant to the drugs we currently have available. The innate host defense peptide (HDP) repertoire present in animals is a wealth of potential antimicrobial agents that could be mined to meet these needs. While much of the body of research regarding HDPs is in the context of bacteria, there is increasing evidence that they can be an effective source for antivirals. Peptides can be identified in a number of ways, including eco-conservation-minded approaches. Those shown to have antiviral properties can be modified to exhibit desired properties as the relationship between structure and function is elucidated and then developed into therapeutics for human use. This review looks at the discovery and therapeutic potential of HDPs for human viral infections.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antimicrobial peptide; Antiviral; Drug discovery; Host defense peptide

Mesh:

Substances:

Year:  2018        PMID: 29524585     DOI: 10.1016/j.semcdb.2018.03.001

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  12 in total

1.  Advances in Antiviral Material Development.

Authors:  Lili Liang; Ashiq Ahamed; Liya Ge; Xiaoxu Fu; Grzegorz Lisak
Journal:  Chempluschem       Date:  2020-08-21       Impact factor: 3.210

2.  AntiVPP 1.0: A portable tool for prediction of antiviral peptides.

Authors:  Jorge Félix Beltrán Lissabet; Lisandra Herrera Belén; Jorge G Farias
Journal:  Comput Biol Med       Date:  2019-02-19       Impact factor: 4.589

3.  Biological Properties of a Novel Multifunctional Host Defense Peptide from the Skin Secretion of the Chaco Tree Frog, Boana raniceps.

Authors:  Carlos José Correia Santana; Ana Carolina Martins Magalhães; César Augusto Prías-Márquez; Diego A Falico; Agenor C M Dos Santos Júnior; Beatriz D Lima; Carlos André Ornelas Ricart; Denise Regina Bairros de Pilger; Rafaela Milan Bonotto; Carolina Borsoi Moraes; Lúcio H Freitas-Júnior; Alice da Cunha Morales Álvares; Sonia Maria Freitas; Isabelle S Luz; Osmindo Rodrigues Pires; Wagner Fontes; Mariana S Castro
Journal:  Biomolecules       Date:  2020-05-20

Review 4.  Antiviral peptides as promising therapeutic drugs.

Authors:  Liana Costa Pereira Vilas Boas; Marcelo Lattarulo Campos; Rhayfa Lorrayne Araujo Berlanda; Natan de Carvalho Neves; Octávio Luiz Franco
Journal:  Cell Mol Life Sci       Date:  2019-05-17       Impact factor: 9.261

Review 5.  Antiviral activities and applications of ribosomally synthesized and post-translationally modified peptides (RiPPs).

Authors:  Yuxin Fu; Ate H Jaarsma; Oscar P Kuipers
Journal:  Cell Mol Life Sci       Date:  2021-02-02       Impact factor: 9.261

6.  Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture.

Authors:  Allison Bakovic; Kenneth Risner; Nishank Bhalla; Farhang Alem; Theresa L Chang; Warren K Weston; Jane A Harness; Aarthi Narayanan
Journal:  Viruses       Date:  2021-02-09       Impact factor: 5.048

Review 7.  Potential "biopeptidal" therapeutics for severe respiratory syndrome coronaviruses: a review of antiviral peptides, viral mechanisms, and prospective needs.

Authors:  Tolulope Joshua Ashaolu; Asad Nawaz; Noman Walayat; Ibrahim Khalifa
Journal:  Appl Microbiol Biotechnol       Date:  2021-04-19       Impact factor: 4.813

Review 8.  Anurans against SARS-CoV-2: A review of the potential antiviral action of anurans cutaneous peptides.

Authors:  Marjoriane de Amaral; Julia Ienes-Lima
Journal:  Virus Res       Date:  2022-04-14       Impact factor: 6.286

9.  Compelling Evidence for the Activity of Antiviral Peptides against SARS-CoV-2.

Authors:  Miray Tonk; Daniel Růžek; Andreas Vilcinskas
Journal:  Viruses       Date:  2021-05-14       Impact factor: 5.048

10.  An Antiviral Peptide from Alopecosa nagpag Spider Targets NS2B-NS3 Protease of Flaviviruses.

Authors:  Mengyao Ji; Tengyu Zhu; Meichen Xing; Ning Luan; James Mwangi; Xiuwen Yan; Guoxiang Mo; Mingqiang Rong; Bowen Li; Ren Lai; Lin Jin
Journal:  Toxins (Basel)       Date:  2019-10-10       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.